Onartuzumab (MetMAb)

onartuzumab · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Onartuzumab (MetMAb), covering 2016-08-09 to 2016-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]

See pricing